Big Peninsula biotech buyout means happy returns for Kleiner Perkins, other VCs
May 10, 2018 at 17:50 PM EDT
Legendary venture capital firm Kleiner Perkins Caufield & Byers bought into Redwood City's ARMO BioSciences Inc. in December 2012 when Series A shares sold for $1. It stuck with the company into a January IPO at $17 and now with a $50-per-share buyout by Eli Lilly & Co.
